Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by mmarquison Jun 15, 2011 11:38am
371 Views
Post# 18718333

RE: Spoke with Dr. Davidoff .....

RE: Spoke with Dr. Davidoff .....csV2,

I can easily ignore or dismiss the wildly insane rants of nut-jobs like this fellow HaHaHa.
 
But If you truly are a longtime sss shareholder and your post was meant to enlighten or to support shareholders expectations of bighter events around the corner I'm afraid it failed to do that...instead, personally, I find it quite depressing. 

Your 'discussion' with him simply reinforces the impression that many shareholders have, given the absolute lack of clear public information from the company, that virtually nothing is being done to be pro-active...the company is sleepily waiting on other parties to set our agenda and future path.

Too bad.

M
Bullboard Posts